Abstract
I describe a case of tachyphylaxis to pramipexole and its management in a patient with bipolar I disorder.
Keywords: Bipolar, Bipolar depression, Drug holiday, Loss of response, Pramipexole, Tachyphylaxis, Tolerance, caramazepine, lamotrigine, modafinil, quetiapine, Parkinson's disease, valproic acid, depression, antidepressants
Letters in Drug Design & Discovery
Title: Pramipexole Tachyphylaxis and its Management in Bipolar Depression
Volume: 9 Issue: 1
Author(s): Verinder Sharma
Affiliation:
Keywords: Bipolar, Bipolar depression, Drug holiday, Loss of response, Pramipexole, Tachyphylaxis, Tolerance, caramazepine, lamotrigine, modafinil, quetiapine, Parkinson's disease, valproic acid, depression, antidepressants
Abstract: I describe a case of tachyphylaxis to pramipexole and its management in a patient with bipolar I disorder.
Export Options
About this article
Cite this article as:
Sharma Verinder, Pramipexole Tachyphylaxis and its Management in Bipolar Depression, Letters in Drug Design & Discovery 2012; 9 (1) . https://dx.doi.org/10.2174/157018012798193008
DOI https://dx.doi.org/10.2174/157018012798193008 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Hot Topic: Organic Solute Transporters and Diseases: Potential Therapeutic Targets)
Current Molecular Pharmacology Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain
Current Neuropharmacology Lamotrigine Pharmacokinetics During Anticonception and Pregnancy
Letters in Drug Design & Discovery Mood Disorders in Elderly Population: Neurostimulative Treatment Possibilities
Recent Patents on CNS Drug Discovery (Discontinued) Analysis of Functional Brain Images Using Population-Based Probabilistic Atlas
Current Medical Imaging α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease
Current Drug Targets Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology Association between <i>Toxoplasma gondii</i> Infection and Headache: A Systematic Review and Meta-Analysis
Infectious Disorders - Drug Targets Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells
CNS & Neurological Disorders - Drug Targets Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets Treatment of Estrogen Receptor-Positive Breast Cancer
Current Medicinal Chemistry Status Analysis of Herbal Drug Therapies in Epilepsy: Advancements in the Use of Medicinal Plants with Anti-inflammatory Properties
Combinatorial Chemistry & High Throughput Screening HIV-1 Reactivation Induced by Apicidin Involves Histone Modification in Latently Infected Cells
Current HIV Research Synthesis and Antioxidant Activity of Indole Derivatives Containing 4-Substituted Piperazine Moieties
Letters in Drug Design & Discovery 2-Arylindoles: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activity
Current Medicinal Chemistry Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry Free Radicals in Living Systems: In Vivo Detection of Bioradicals with EPR Spectroscopy
Current Organic Chemistry synthesis and Structure-Activity Relationships of 2,3-Benzodiazepines as AMPA Receptor Antagonists
Mini-Reviews in Medicinal Chemistry Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Current Neuropharmacology